Shanghai Henlius Biotech (HKSE:02696) Days Payable : 157.21 (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai Henlius Biotech Days Payable?

Shanghai Henlius Biotech's average Accounts Payable for the six months ended in Dec. 2024 was HK$721 Mil. Shanghai Henlius Biotech's Cost of Goods Sold for the six months ended in Dec. 2024 was HK$837 Mil. Hence, Shanghai Henlius Biotech's Days Payable for the six months ended in Dec. 2024 was 157.21.

The historical rank and industry rank for Shanghai Henlius Biotech's Days Payable or its related term are showing as below:

HKSE:02696' s Days Payable Range Over the Past 10 Years
Min: 150.27 Med: 385.26 Max: 5500.89
Current: 150.27

During the past 8 years, Shanghai Henlius Biotech's highest Days Payable was 5500.89. The lowest was 150.27. And the median was 385.26.

HKSE:02696's Days Payable is ranked better than
55.04% of 705 companies
in the Biotechnology industry
Industry Median: 115.08 vs HKSE:02696: 150.27

Shanghai Henlius Biotech's Days Payable increased from Dec. 2023 (138.02) to Dec. 2024 (157.21). It may suggest that Shanghai Henlius Biotech delayed paying its suppliers.

Shanghai Henlius Biotech Days Payable Historical Data

The historical data trend for Shanghai Henlius Biotech's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Henlius Biotech Days Payable Chart

Shanghai Henlius Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Get a 7-Day Free Trial

525.48

234.92

245.03

157.43

152.57

Shanghai Henlius Biotech Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Days Payable	Get a 7-Day Free Trial										189.84	167.53	138.02	141.41	157.21

Competitive Comparison of Shanghai Henlius Biotech's Days Payable

For the Biotechnology subindustry, Shanghai Henlius Biotech's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Henlius Biotech's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Henlius Biotech's Days Payable distribution charts can be found below:

* The bar in red indicates where Shanghai Henlius Biotech's Days Payable falls into.

Save Embed

;

Save Embed

;

Shanghai Henlius Biotech Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Shanghai Henlius Biotech's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (595.907	+	778.439)	/	2 )	/	1643.987	*	365
=	687.173					/	1643.987	*	365
=	152.57

Shanghai Henlius Biotech's Days Payable for the quarter that ended in Dec. 2024 is calculated as:

	Days Payable (Q: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
=	( (664.383	+	778.439)	/	2 )	/	837.453	*	365 / 2
=	721.411					/	837.453	*	365 / 2
=	157.21

Shanghai Henlius Biotech Days Payable Related Terms

Thank you for viewing the detailed overview of Shanghai Henlius Biotech's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Henlius Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Henlius Biotech Inc (HKSE:02696) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

B8 Building, No. 188 Yizhou Road, 11th Floor, Xuhui District, Shanghai, CHN, 200233

Website

https://www.henlius.com

Shanghai Henlius Biotech Inc is a biopharmaceutical company in China with the vision to offer affordable and biologics for patients with a focus on oncology and autoimmune diseases. The Group is engaged in biopharmaceutical R&D, biopharmaceutical services, and biopharmaceutical production and sales. It operates in Mainland China, Asia Pacific (excluding Mainland China), North America, South America, Oceania, and Europe. The company products include HLX01 Rituximab, HLX02(trastuzumab), and others.

Executives

Ubs Group Ag
Golden Valley Value Select Master Fund	2101 Beneficial owner
Vistra Trust (singapore) Pte. Limited	2301 Trustee
Lvc Sg Management Pte. Ltd.	2201 Interest of corporation controlled by you
Lvc Management Holdings Limited	2201 Interest of corporation controlled by you
Lin Lijun	2201 Interest of corporation controlled by you
Qatar Investment Authority	2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical (group) Co., Ltd.	2201 Interest of corporation controlled by you
Guo Guangchang	2201 Interest of corporation controlled by you
Fosun International Limited	2201 Interest of corporation controlled by you
Fosun International Holdings Ltd.	2201 Interest of corporation controlled by you
Fosun Industrial Co., Limited	2101 Beneficial owner
Fosun Holdings Limited	2201 Interest of corporation controlled by you
Liu Scott Shi-kau	2201 Interest of corporation controlled by you

Shanghai Henlius Biotech Headlines

No Headlines